Alpha-Synuclein Protein Aggregates, Spinal Fluid

Alphabetical Test listing

Alpha-Synuclein Protein Aggregates, Spinal Fluid-994

  
Alpha-Synuclein Protein Aggregates, Spinal Fluid
  
994
  
LAB994
  
MSO
  
SAAmplify-aSYN
SYNTap
Amprion
Alpha-Synuclein Aggregates
Parkinson Disease (PD)
Dementia with Lewy bodies (DLB)
Lewy body disease (LBDCSF)
Alzheimer disease (AD)
Mild cognitive impairment (MCI)
Multiple system atrophy (MSA)
RT-QuIC
Seed Amplification Assay (SAA)
Synucleinopathy
AMP1200
  

Detection of pathogenic alpha-synuclein (alpha-synuclein aggregates) in adult patients being assessed for clinically uncertain cognitive decline or clinically uncertain parkinsonian syndromes

  
Cerebrospinal fluid (CSF)
  
1.0 mL
  
0.3 mL
  
  1. Perform lumbar puncture and discard the first 1 to 2 mL of cerebrospinal fluid (CSF).
  2. Collect CSF directly into a sterile polypropylene tube.
  3. Freeze sample upright 
  
  1. Inspect specimen for visible discoloration.Specimen must be clear and colorless to perform testing.
  2. Do not centrifuge
  

Screw-capped polypropylene vial/tube, sterile (Mayo)

  

Frozen (preferred) - 60 days

Refrigerated - 14 days

  
  • Hemolysis
  • Icterus
  • Unclear/discolored specimen
  • Specimens not collected in polypropylene collection tubes
  
Amprion Inc via Mayo Clinic Laboratories (ASYNC)
  
Varies
  
15 - 18 days
  

Seed Amplification Assay (SAA)

  

An interpretive report will be provided

  
Results must be interpreted in conjunction with other patient clinical information.
  
0393U
  
05/05/2025
  
05/05/2025